• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ARIAD Pharmaceuticals Inc

+ Add to Watchlist


5.7100 USD 0.1200 2.15%

As of 20:10:00 ET on 10/23/2014.

Snapshot for ARIAD Pharmaceuticals Inc (ARIA)

Open: 5.6500 Day's Range: 5.5500 - 5.8200 Volume: 5,174,226
Previous Close: 5.5900 52wk Range: 2.1500 - 9.8300 1-Yr Rtn: +70.45%

Stock Chart for ARIA

No chart data available.
  • ARIA:US 5.7100
  • 1D
  • 1M
  • 1Y
Interactive ARIA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ARIA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.3134
Est. EPS (USD) (12/2014) -1.1580
Est. PEG Ratio -
Market Cap (M USD) 1,067.84
Shares Outstanding (M) 187.01
30 Day Average Volume 7,354,423
Price/Book (mrq) 8.6913
Price/Sale (ttm) 21.6771
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ARIA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ARIA

ARIAD Pharmaceuticals, Inc. is a global oncology company focused on the discovery, development and commercialization of medicines to transform the lives of cancer patients. The Company's approach to structure-based drug design has led to several molecularly targeted medicines for drug-resistant or difficult-to-treat cancers.

Harvey J BergerChairman/President/CEOTimothy P ClacksonChief Scientific Ofcr/Pres:R&D
Edward M FitzgeraldExec VP/CFO/TreasurerMartin J Duvall "Marty"Exec VP/Chief Commercial Ofcr
More Company Profile & Key Executives for ARIA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil